Recombinant human granulocyte-macrophage colony stimulating factor gel

A technology of colony-stimulating factor and macrophages, which can be applied in drug combinations, peptide/protein components, skin diseases, etc., can solve the problems of inconvenient use, and achieve convenient portability and use, stable and controllable quality, and clear mechanism of action Effect

Inactive Publication Date: 2003-08-13
HARBIN PHARMA GROUP TECH CENT
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is aimed at the inconvenient technical problems and deficiencies in the use of freeze-dried dosage-type medical external-use biological products, and researches and develops a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0006] An example is given below. Choose 350 grams of glycerol, 15 grams of carbomer, 10 grams of benzzet, 5 grams of sodium hydroxide, 10 grams of human albumin, and 10 undiluted solution 6 International unit, the rest uses purified water, a total of 1000 grams, the weight ratio of each component is: glycerol 35%, carbomer 1.5%, benzine 1%, sodium hydroxide 0.5%, human albumin 1%, Purified water is added to 100%. Among the ingredients of the formula, glycerol is used as a matrix, stabilizer, and protective agent; carbomer is used as a drug carrier; benzalze is used as a transdermal absorption enhancer; sodium hydroxide is used as a neutralizer to shape the gel and adjust the pH of the gel at the same time (PH), which keeps the original solution biologically active; human albumin acts as a stabilizer and protective agent. The biological product is manufactured under normal temperature conditions. The product process is as follows: Put 15 grams of carbomer in an emulsification tank...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A gel of recombinant human granulocyte-macrophage colony stimulating factor for treating ulcer, scald, burn, mucitis and mucosa wound is prepared from carbomer, propanetriol, sodium hydroxide, raw liquid, human plasma albumin, purified water, etc. Its advantages are high curative effect and low dosage.

Description

technical field [0001] The invention relates to a medicinal biological product, which is a biotechnological medicine for external use to treat skin and mucous membrane wound diseases such as ulcers, scalds and burns. Background technique [0002] Recombinant human granulocyte-macrophage colony-stimulating factor is a product of modern biotechnology, which is an endogenous biologically active substance in the human body. The GM-CSF stock solution is stored at room temperature, and its activity will gradually decrease with time. In order to prolong the biological activity of the stock solution as far as possible, the current medicinal recombinant human epidermal growth factor (rhEGF) freeze-dried external preparations and external recombinant human basic fibroblast growth factor (rhbFGF) are all made into freeze-dried dosage forms to achieve the purpose of prolonging the biological activity of the stock solution. The purpose of biological activity is to prolong the validity p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/00A61K38/19A61K38/22A61P17/02
Inventor 王忠
Owner HARBIN PHARMA GROUP TECH CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap